This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
An oral small molecule from New York-based biotech Oligomerix curbed the tanglin...
Takeda’s revamped R&D strategy means the drugmaker’s oncology leaders are priori...
With Concentra Biosciences expanding its stock influence on Pliant Therapeutics ...
Gilead’s Sandra Patterson has “decided to leave the company” after two years in ...
As always, if you know of layoffs occurring at a biotech, please reach out to th...
Sutro Biopharma is undergoing a seismic shake-up—jettisoning its CEO, half of it...
Dubbed Monarch Quest, the Nvidia-backed AI program can interface with GE HealthC...
As always, if you know of layoffs occurring at a biotech, please reach out to th...
ImmunoPrecise Antibodies has secured a collaboration with an undisclosed “leadin...
BVI said the move fully refinances its debt and adds new equity, both from TPG a...
Artificial intelligence company Hologen AI has committed up to $430 million as p...
Sotio Biotech is pushing deeper into bispecific antibody-drug conjugates, taking...
Takeda’s revamped R&D strategy means the drugmaker’s oncology leaders are priori...
The National Institutes of Health is reportedly continuing its grant-canceling s...
Synthetic biology specialist Gro Biosciences, born out of the George Church Lab ...
Samsung backed the Alzheimer’s disease blood test developer C2N Diagnostics, wit...
Researchers at Waseda University in Japan have identified a gene that, when rend...
Tech firm Clario is boosting its electronic clinical outcome assessment (eCOA) o...
Dubbed Monarch Quest, the Nvidia-backed AI program can interface with GE HealthC...
GSK’s ViiV Healthcare has shared clinical data on three potential long-acting HI...
Insilico's series E round was led by Hong Kong-based firm Value Partners, and jo...
Emergent BioSolutions is investing in Swiss biotech Rocketvax, inking a deal des...
China’s Harbour BioMed has launched a new biotech to develop bispecific antibodi...
Roche is paying $1.65 billion in confirmed upfront fees to add to its burgeoning...